Business Context and Reporting Period
Company: Crane Co. (Note: Input metadata referenced "Crane NXT, Co.", but the filing is for Crane Co.)
Filing Type: Form 8-K (Current Report)
Date of Report: January 26, 2015
Reporting Period: Quarter ended December 31, 2014
Context: The filing reports results of operations for the fourth quarter of 2014 and provides a detailed update on asbestos-related litigation, claims activity, and liability estimates.
Key Financial Metrics
Asbestos-Related Costs (Gross, before insurance recoveries and tax effects):
- 2014 Total Costs Incurred: $81.1 million (Settlement/Indemnity: $25.3 million; Defense: $55.9 million).
- 2013 Total Costs Incurred: $90.8 million.
- 2012 Total Costs Incurred: $96.1 million.
Asbestos-Related Cash Payments (Pre-tax, net of insurance receipts):
- 2014 Net Cash Payments: $61.3 million.
- 2013 Net Cash Payments: $62.8 million.
- 2012 Net Cash Payments: $78.0 million.
Liability and Insurance Estimates (As of December 31, 2014):
- Total Asbestos Liability Recorded: $614 million (covers claims through 2021).
- Current Portion of Liability: $79 million (expected payments within 12 months).
- Probable Insurance Recovery Asset: $147 million.
- Estimated Reimbursement Rate: Approximately 25% of the liability.
General Financials: The filing text does not provide specific values for total revenue, net profit, operating margins, or total debt. These figures are referenced as being contained in the attached press release (Exhibit 99.1) and financial data supplement (Exhibit 99.2), which are not included in the source text.
Material Changes vs. Prior Period
- Claims Activity: Ending active asbestos claims decreased from 51,490 in 2013 to 47,507 in 2014. New claims filed in 2014 were 2,743, down from 2,950 in 2013.
- Cost Trends: Total gross costs incurred decreased by approximately 10.7% year-over-year ($81.1 million in 2014 vs. $90.8 million in 2013).
- Settlement Costs: Average settlement cost per resolved claim increased to $3,800 in 2014, compared to $3,300 in 2013 and $6,300 in 2012.
- Liability Estimate: Management determined no change in the asbestos liability estimate was warranted for the period ended December 31, 2014, as actual experience approximated assumptions.
Outlook, Risks, and Contingencies
Management Commentary: The Company utilizes an external expert (Hamilton, Rabinovitz & Associates) to estimate liabilities based on an 11-quarter reference period. The forecast period extends through 2021; costs beyond this date cannot be reasonably estimated.
Key Risks and Uncertainties:
- Litigation Volatility: Significant adverse jury verdicts that withstand appeal could materially change the liability estimate. The filing details several pending appeals and recent verdicts (e.g., Peraica, Sweberg, Hackshaw, Garvin) where final judgment amounts are not yet included in incurred costs.
- Insurance Recovery: Reimbursements depend on the financial viability of insurers and the interpretation of policy terms. While 25% recovery is estimated, actual amounts vary.
- Legislative and Judicial Changes: Changes in state laws or federal legislation regarding asbestos could alter claim dynamics and costs.
- Forecast Limitations: The Company explicitly states it cannot estimate costs for claims filed after 2021 due to high uncertainty.
Investor Verification Checklist
- Verify the specific revenue and earnings figures for Q4 2014 in the attached Exhibit 99.1 (Earnings Press Release), as they are not detailed in the 8-K text.
- Monitor the status of pending appeals in high-value cases (e.g., Peraica, Sweberg, Hackshaw) which could impact future liability accruals.
- Review the Exhibit 99.2 (Financial Data Supplement) for detailed liquidity, debt, and cash flow metrics not present in this summary.
- Assess the stability of the 25% insurance recovery rate assumption given the financial health of the Company's excess insurers.
- Track the number of new mesothelioma claims filed, as this is cited as a primary driver of the liability estimate.